Compare CPNG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPNG | KVUE |
|---|---|---|
| Founded | 2010 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Specialty Chemicals |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7B | 33.1B |
| IPO Year | 2021 | 2023 |
| Metric | CPNG | KVUE |
|---|---|---|
| Price | $19.04 | $19.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $32.00 | $19.64 |
| AVG Volume (30 Days) | 21.8M | ★ 49.8M |
| Earning Date | 05-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.37% |
| EPS Growth | 37.50 | ★ 40.74 |
| EPS | 0.11 | ★ 0.76 |
| Revenue | ★ $34,534,000,000.00 | $15,124,000,000.00 |
| Revenue This Year | $17.71 | $4.07 |
| Revenue Next Year | $12.49 | $2.92 |
| P/E Ratio | $143.88 | ★ $25.00 |
| Revenue Growth | ★ 14.09 | N/A |
| 52 Week Low | $16.75 | $14.02 |
| 52 Week High | $34.08 | $25.17 |
| Indicator | CPNG | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 67.91 |
| Support Level | $18.55 | $16.73 |
| Resistance Level | $20.98 | $22.73 |
| Average True Range (ATR) | 0.84 | 0.37 |
| MACD | 0.30 | 0.03 |
| Stochastic Oscillator | 60.82 | 92.21 |
Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.